Pfizer press release continues

New York, January 27, 2023. Allegations, gain of function and directed evolution research, Friday, January 27, 2023 - 08:00pm https://www.pfizer.com/news/announcements/pfizer-responds-research-claims#.Y9WTkZsflV4.mailto the company would like to set the record straight. Seek medical attention right away if you have any of the following symptoms: Difficulty breathing, swelling of the face and throat, a fast heartbeat, a bad rash all over the body, dizziness, and weakness Myocarditis (inflammation of the heart muscle) Pericarditis (inflammation of the lining outside the heart), have occurred in some people who have received COMIRNATY® (COVID-19 vaccine, mRNA) or Pfizer-BioNTech COVID-19 Vaccine. The observed risk Higher among adolescent males and adult males under 40 years of age (compared to females and older males) Risk is highest in males 12 through 17 years of age. In most of these people Symptoms began within a few days following receipt of the second dose of vaccine. Magnitude of risk not specified in press release From the recent ‘Vaccine’ paper https://pubmed.ncbi.nlm.nih.gov/36055877/ Pfizer mRNA COVID-19 vaccines, associated with an excess risk of serious adverse events of special interest of 10.1 per 10,000 vaccinated Moderna mRNA COVID-19 vaccines, associated with an excess risk of serious adverse events of special interest of 15.1 per 10,000 vaccinated Combined, 1 in 800 Latest risk figures from UK Health Security Agency (UKHSA) presentation to the Joint Committee on Vaccination and Immunisation (JCVI) https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1131409/appendix-1-of-jcvi-statement-on-2023-covid-19-vaccination-programme-8-november-2022.pdf Table 3: NNV for prevention of hospitalisation(and severe hospitalisation)for different programmes 16 – 19 Years, Autumn booster 73,500 (185,100) 20 – 29 Years, Autumn booster No risk group, 169,200 (706,500) In a risk group, 7,500 (59,500) Side effects that have been reported with these vaccines include (direct from Pfizer) Severe allergic reactions Non-severe allergic reactions such as rash, itching, hives, or swelling of the face Myocarditis Pericarditis Injection site pain Tiredness Headache Muscle pain Chills Joint pain Fever Injection site swelling Injection site redness Nausea Feeling unwell Swollen lymph nodes (lymphadenopathy) Decreased appetite Diarrhea Vomiting Arm pain Fainting in association with injection of the vaccine Unusual and persistent irritability Unusual and persistent poor feeding Unusual and persistent fatigue or lack of energy Unusual and persistent cool, pale skin Dizziness These may not be all the possible side effects of these vaccines. Call the vaccination provider or healthcare provider about bothersome side effects or side effects that do not go away. Individuals should always ask their healthcare providers for medical advice about adverse events. Report vaccine side effects using Vaccine Adverse Event Reporting System (VAERS). The VAERS toll-free number is 1‐800‐822‐7967 or report online to www.vaers.hhs.gov/reportevent.html. In addition, individuals can report side effects to Pfizer Inc. at www.pfizersafetyreporting.com or by calling 1-800-438-1985 Tell your vaccination provider about all of your medical conditions, including if you: have any allergies have had myocarditis or pericarditis have a fever have a bleeding disorder or are on a blood thinner are immunocompromised or are on a medicine that affects the immune system are pregnant, plan to become pregnant, or are breastfeeding have received another COVID-19 vaccine have ever fainted in association with an injection The vaccine may not protect everyone Fact-based information rooted in sound science is vitally important to overcoming the COVID-19 pandemic, and Pfizer remains committed to transparency and helping alleviate the devastating burden of this disease.